Evidence map›Paper›PMID 30999236›Full record

ReviewCurrent opinion in structural biology2019

Gateway to the Golgi: molecular mechanisms of nucleotide sugar transporters.

Joanne L Parker, Simon Newstead

Open access · hybridAbstract readReview
In one paragraph

Review in Current opinion in structural biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. The NMR studies of CMP inhibition of polysialylation.Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. ChIP-seq identifiesFrontiers in physiology · 2023
    Article
  16. Article
  17. An Overview ofFrontiers in cell and developmental biology · 2021
    Review
  18. Review
  19. The Structure and Mechanism of Drug Transporters.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  20. Global view of human protein glycosylation pathways and functions.Nature reviews. Molecular cell biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Joanne L ParkerDepartment of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK. Electronic address: joanne.parker@bioch.ox.ac.uk.
Simon NewsteadDepartment of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK. Electronic address: simon.newstead@bioch.ox.ac.uk.
University of Oxford · GB

Funding

Medical Research Council MR/S021043/1Wellcome Trust 102890Wellcome Trust 102890/Z/13/Z
6 · The paper itself

Abstract

The Golgi apparatus plays a central role in the secretory pathway as a hub for posttranslational modification, protein sorting and quality control. To date, there is little structural or biochemical information concerning the function of transporters that reside within this organelle. The SLC35 family of nucleotide sugar transporters link the synthesis of activated sugar molecules and sulfate in the cytoplasm, with the luminal transferases that catalyse their attachment to proteins and lipids during glycosylation and sulfation. A recent crystal structure of the GDP-mannose transporter has revealed key sequence motifs that direct ligand recognition and transport. Further biochemical studies unexpectedly found a requirement for short chain lipids in activating the transporter, suggesting a possible route for transport regulation within the Golgi.

Indexed as

AnimalsGolgi ApparatusHumansMembrane Transport ProteinsNucleotidesSugarsMembrane Transport ProteinsNucleotidesSugars

Identifiers

PMID30999236
PMCPMC6504644
OpenAlexW2937243110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.